Wegovy is licensed for weight loss rather than diabetes, though the related medication Ozempic uses the same drug for diabetes
Theres no published evidence to date that supports the use of this therapy for serious or chronic diseases, although individual patients may claim that it was beneficial for them
For instance, in the db/db mouse model, the levels of inflammatory factors such as IL-1, IL-6, CCL2, and CXCL1 in the muscle tissue of mice all decreased significantly after treatment with GLP-1RA dulaglutide
Long-Acting ( CJC-1295 w/ DAC): Once weekly
This is why it can be administered as a simple, once-weekly injection
The American College of Sports Medicine suggests 200-300 minutes of moderate-intensity aerobic activity per week for weight loss maintenancesignificantly more than the 150 minutes recommended for general health